> top > projects > Inflammaging > docs > PubMed:33041824 > annotations
Inflammaging  

PubMed:33041824 JSONTXT 20 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1 0-98 Sentence denotes Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications:
T1 0-98 Sentence denotes Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications:
T2 99-132 Sentence denotes A Review of the Current Evidence.
T2 99-132 Sentence denotes A Review of the Current Evidence.
T3 133-245 Sentence denotes The impact of the COVID-19 pandemic has been dramatic worldwide, with China, Italy, and now US at its epicenter.
T3 133-245 Sentence denotes The impact of the COVID-19 pandemic has been dramatic worldwide, with China, Italy, and now US at its epicenter.
T4 246-385 Sentence denotes Researchers and clinicians are studying and testing different approaches in the attempt to prevent the infection and minimize its severity.
T4 246-385 Sentence denotes Researchers and clinicians are studying and testing different approaches in the attempt to prevent the infection and minimize its severity.
T5 386-599 Sentence denotes Major efforts are focused on optimizing mechanical ventilation, antiviral, and supportive treatment; however, the role of heparin and low molecular weight (LMW) heparin in this setting has been largely overlooked.
T5 386-599 Sentence denotes Major efforts are focused on optimizing mechanical ventilation, antiviral, and supportive treatment; however, the role of heparin and low molecular weight (LMW) heparin in this setting has been largely overlooked.
T6 600-1101 Sentence denotes This review summarizes the available evidence about the role of heparan sulfate as a key entry mechanism for SARS-CoV-2; the efficacy of heparin and LMW heparin in counteracting its entry into the cell, the recent experimental findings obtained in in vitro studies using the LMW heparin enoxaparin Inhixa®, the role of heparin and LMW heparin in modulating the cytokine storm, and the evidence for the use of LMW heparin in the prevention and treatment of the thromboembolic complications of COVID-19.
T6 600-1101 Sentence denotes This review summarizes the available evidence about the role of heparan sulfate as a key entry mechanism for SARS-CoV-2; the efficacy of heparin and LMW heparin in counteracting its entry into the cell, the recent experimental findings obtained in in vitro studies using the LMW heparin enoxaparin Inhixa®, the role of heparin and LMW heparin in modulating the cytokine storm, and the evidence for the use of LMW heparin in the prevention and treatment of the thromboembolic complications of COVID-19.
T7 1102-1208 Sentence denotes The available evidence suggests that LMW heparin appears as a promising tool in the treatment of COVID-19.
T7 1102-1208 Sentence denotes The available evidence suggests that LMW heparin appears as a promising tool in the treatment of COVID-19.
T8 1209-1381 Sentence denotes Whether its systematic use is associated with a reduction in complications and ultimately mortality of these patients is being tested in several studies starting worldwide.
T8 1209-1381 Sentence denotes Whether its systematic use is associated with a reduction in complications and ultimately mortality of these patients is being tested in several studies starting worldwide.